XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.3
Divestitures - Narrative (Details)
$ in Millions
3 Months Ended 6 Months Ended 9 Months Ended
Nov. 29, 2022
USD ($)
Sep. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Sep. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Jun. 30, 2024
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2024
USD ($)
Oct. 01, 2023
product
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
TSA income related to divestitures   $ 10.2     $ 92.0     $ 143.2 $ 269.4    
Pre-tax gain on sale               (295.8) 0.0    
Goodwill impairment charge   0.0     0.0     0.0 32.0    
Goodwill, impairment loss               321.0 0.0    
Cash proceeds received               2,510.2 48.0    
Biocon Biologics                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Gain on equity securities   (39.4)     19.1     (368.7) 50.6    
Licensing Agreements                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Write down of intangible assets         32.0 $ 172.9     32.0    
Emerging Markets Segment                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Goodwill, impairment loss               0.0      
Disposal Group, Disposed of by Sale, Not Discontinued Operations                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Number of women's healthcare product rights sold | product                     2
Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Goodwill impairment charge           374.2 $ 136.4        
Loss on disposal             85.2        
Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations | Inventories                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Goodwill impairment charge           84.3     19.2    
Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations | Emerging Markets Segment                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Goodwill, impairment loss           $ 117.0          
Biocon Biologics                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
TSA income related to divestitures   27.5     $ 47.2     47.0 $ 139.8    
Biocon Biologics | Disposal Group, Disposed of by Sale, Not Discontinued Operations                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Consideration received on disposal $ 3,000.0                    
Cash proceeds received 2,000.0                    
Noncash consideration received $ 1,000.0                    
Ownership percentage in disposed asset 12.90%                    
Deferred consideration   335.0           335.0      
Working capital adjustment $ 250.0                    
Contingent consideration paid             $ 220.0        
Disposal Group, Including Discontinued Operation, Deferred Consideration Received   145.0                  
Biocon Biologics | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Scenario, Forecast                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Deferred consideration                   $ 160.0  
Women's Health Products | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Other Income                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Pre-tax gain on sale   2.0           (77.6)      
Women's Health Products | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Selling, General and Administrative Expenses                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Pre-tax gain on sale   10.8   $ 156.2              
OTC Business | Disposal Group, Held-for-Sale, Not Discontinued Operations                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Goodwill impairment charge     $ 734.7                
Goodwill, impairment loss     580.1                
Write-down on disposal group   92.6 $ 154.7         340.2      
API Business | Disposal Group, Held-for-Sale, Not Discontinued Operations                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Write-down on disposal group   $ 15.1           $ 32.5